TMC125
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for TMC125, covering 2010-04-28 to 2014-06-20. Get the full timeline:
Most recent: Clinical Trial Update: TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options. [Phase 3]